Insider filing
Traded Sep 14 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 14, 2026 · Filed Sep 16, 2026
BrightSpring Health Services's President, PharMerica sold $874K of BrightSpring Health Services shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$874,383
Shares × reported transaction price
45 days after results of Jul 31, 2026, 46 days before results of Oct 30, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.0% | +0.6% | −1.6% |
| 30 days | +8.3% | +0.5% | +7.8% |
Past results only. Not a forecast.
Insider filing
Traded Sep 14 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Sep 14 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Fund moves
6 tracked managers disclosed the same change for Q1 2026. From a 13F filed Aug 14, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.